Adamis Pharmaceuticals (NASDAQ: ADMP) is gaining again despite news that Mylan (NYSE: MYL) announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Trader Talk

Generic EpiPen Pricing Parity and Less than 1% Share Supports $10 Adamis (ADMP) Target Price - Maxim GroupAugust 29, 2016 1:04 PM Adamis Pharmaceuticals (ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - BloombergAugust 26, 2016 4:17 PM Adamis Pharmaceuticals (ADMP) Ramps to Session Highs on VolumeAugust 26, 2016 1:33 PM